Welcome to my blog archive! (See Blog Topics.) Blogging allows me to publish my opinions any time I feel the urge and without stuffing the e-mail boxes of Pharma Marketing News subscribers. Luckily, other people like to read my opinions, as the following comment shows:

"The blog format is perfect. I subscribe by e-mail but I have already connected to more links through the blog that were not apparent to me on the list and I don't have to worry about html filters on my e-mail.

"I have not come across that many blogs that address the pharma world, not ones that I would read anyway, so this is a great start. The whole point of a blog is to write what you think, because when that is visible to the world, that is one more perspective that can elevate or change, confirm or retain the status quo of intelligence.

-- Anonymous commenter

Why don't I just continue to publish my opinions here in Pharma Marketing News? Well, I will continue to do that in my OpEd Pieces. But this OpEd space is limited and appears only once per month (see Pharma Marketing News OpEd Pieces). More importantly, I don't want to turn the newsletter into a platform for my particular point of view. A few words every month is enough.

Meanwhile, if you have any blog-worthy information or opinions drop me a note any time or submit a comment on Pharma Marketing Blog.

johnmack@virsci.com

Access the feed to see the latest posts.

See below for a reverse chronological listing of posts.

Major Topic Areas

• Favorites
• Anti-Obesity Drug Blog Topics
• Buzz/Public Relations/Image
• Cholesterol-lowering Drugs
• Diddies and Spoofs
• Drug Companies
• Drug Safety
• DTC Advertising
• ED, EC, Sexual Performance Drugs
• eMarketing
• FDA
• Importation
• Legal/Regulatory
• Market Research/ROI
• Pain Drugs (Vioxx, etc.)
• Pharma CEOs and Big Wigs
• PhRMA
• Physician Marketing
• Sales & Sales Reps
• Social Media Marketing
• Sleep Aid Drugs
• Unbranded Advertising

Site Feed - add this newsfeed (URL: http://pharmamkting.blogspot.com/atom.xml) to your RSS reader (e.g., Newz Crawler) to keep up to date with the latest Pharma Marketing Blog posts.

You can also receive notice by email whenever a post is made to Pharma Marketing Blog:

Reverse Chronological Listing

Access the feed to see the latest posts.

Posted in November, 2008:

• Entire November 2008 Archive

Posted in October, 2008:

• Entire October 2008 Archive

Posted in September, 2008:

• Boston Legal's Denny Crane Takes on Pharma Marketing. Where does he get his "facts?"
• Are Soon-to-be-Off-Patent Blockbuster Drugs Another "Troubled Asset" Needing Bailout?
• What I Saw at the Doctors' Choice Awards Ceremony
• Bailout Bonanza, Recession Redux
• Pro-Industry Supporters Gather in Washington, DC in Attempt to Put Out "Five Alarm" Industry-Sponsored CME Fire
• Drug Ads from the Doctor's Perspective
• Device Marketing is Easy and Other Learnings from the PharmaMed Conference
• New Yorker Cartoon: A Slice of Medico-Pharma Life!
• Do Privacy Concerns Stand in the Way of Measuring Pharma eMarketing ROI?
• ACCME to Pharma Ad Copywriters: No Double Dipping! Stay Out of Industry-Sponsored CME
• PhRMA Intern and the YouTube Guru
• Drug Samples: To those that have, it shall be given. The rest pay list price!
• Is it time to end pharma sponsored CME?
• Pfizer Saves $1,349,432.90 on New Lipitor Ads!

Posted in August, 2008:

• J&J, Debbie Phelps, You, Me, Facebook: Is This Social Networking?
• Merck's Sales Training "Boner"
• Are You Passionate About Obama or McCain or Neither?
• The Cymbalta Buzz Machine is at Full Throttle!
• Introducing the Politically Incorrect AmbienCR Rooster
• Social Marketing Pharma Style
• A Pharma Sales Rep and a Used Car Salesman Walk into a Bar...
• What's Next: Ban Free Drug Samples?
• Counter-counter Detailing
• It's Official! Pharma is in a Recession
• Rethinking the Value of DTC Advertising
• "Friendly" Pharma Sales Reps Earn More Bucks with Fewer Sales Calls!
• New Image for alliconnect Blog: Skinny Women
• FDA Intern Says Obama's Ad is More Pleasing!
• FDA Intern Learns All About the "Affect Misattribution Procedure"

Posted in July, 2008:

• OOH! Narrowcast DTC Advertising
• Praise for Lyrica Ad: Is This a Joke?
• Lyrica Lightens Up, DTCwise
• Will Viagra be Approved for Antidepressant-Related Sexual Dysfunction in Women?
• Pharma DTC Ads Portray Women as Weak and Battered Victims
• Can a Moratorium-delayed DTC Ad Refer to a Drug as "New"?
• How Risky are Rx Drugs?
• Is This OK Under PhRMA's New Code?
• FDA Intern Gets Her Bonus!
• "Candid Camera" Research Into Physician-Patient Interactions
• Is This Permitted Under New Code of Interactions with Health Professionals?
• Pharma Marketers Sometimes View Patients Merely as Symptoms to be Treated
• What's Your Opinion of PhRMA's New Code?
• Pharma Vendor and Ad Agency Diversity: All Talk, No Action?
• A Novel Approach to Communicating with Physicians
• AAP Guidelines May Help Extend the Patent Life of Lipitor
• FDA Intern vs. Inebriated Advisory Committee Antagonist
• If Doctors, Like Nascar Drivers, Wore Their Sponsors' Logos
• New alli Plan to Gain Market Share: Eliminate the Competition!
• 40over40: Lilly's DTC ED Awareness Campaign in the UK

Posted in June, 2008:

• I Opt-Out of My alli Challenge!
• Marketing Mix of Leading Pharma Advertisers
• Battered Woman Imagery in Pfizer's New Fibromyalgia Ad
• Take alli - I dare you!
• The alli lesson: Pharma marketing is not ready for transparency
• Life Science Profiles of Color: A Response to Racism in the Life Sciences
• Social Media Marketing Not All It's Cracked Up to Be
• Consumers Jazzed by Adverse Events!
• Viagra Induces Major-League Wood!
• Chantix "Roundtable" Apparently Not Round and Not a Table
• Bad News About "Good" Cholesterol Adds to Need for DTC Education
• Evista: "Nobody is pointing a gun at us" says breast cancer advocate with ties to Lilly

Posted in May, 2008:

• Pfizer Invites This Blogger to Chantix Media Roundtable Discussion
• Dear Pfizer: Please invite me to your Chantix roundtable media discussion
• Blogs are Done! WhatÂ’s Next for Pharma Marketing?
• Professional Advertising Doing Well. DTC? Not So Much
• Trains, Planes, School Vans: Unsafe for Chantix Users
• Using Google Maps to Build a Vendor Village
• FDA DTC Review: The House that Troy Built
• Podcast: If You Can't Measure It, You Can't Improve It
• Ruth Day and the Bees Repeat Performance at House DTC Hearing
• 'Twas the night before layoffs.....

Posted in April, 2008:

• Invasive Compliance: A Bitter Pill to Swallow
• What's Behind AstraZeneca's New Push for FDA Preview of DTC Ads?
• Pharma Online Ad Bellwether WebMD Foresees Ad Slowdown
• Violative Viva Viagra Video - Still There!
• The Real Value of Blogs for Marketing Is...
• Zyrtec Telephone Pole Ad Campaign: Guerilla or Gorilla Marketing?
• Zyrtec Reminder Print Ad -- Is It Legal?
• Internet vs. Sales Reps: Which Do Docs Prefer?
• Creativity Outside of Pharma Marketing
• Chantix Road Rage - Revisited
• Doctors (and Patients) were Smarter than Exubera Marketers
• DTC Marketers Heading for Skid Row!
• Need More Moth? Try This!
• 'Round the Sphere: Free Speech No Match for Big Pharma
- PharmaBlogosphere^TM
• Is DTC Bankrupting Pharma?
• Need More Moth? Try This!
• Vytorin Ads Trump Peter Rost on Fox Business News
• 'Round the Sphere: Mothballs and a High Source
- PharmaBlogosphere^TM
• Exciting News: FDA approves new use for CRESTOR
• Pharma Ad Spending Shrinking!

Posted in March, 2008:

• Sepracor Not So Keen to Spend Big on DTC for Its Next Product!
• Pharma Marketing ROI: The Emperor Has No Clothes!
• Pharma Bloggers Gotta Get Tweeting on Twitter!
- PharmaBlogosphere^TM
• Lunesta Moth Being Mothballed as a Result of Negative Marketing ROI
• Pharma Recession, Part Deux: Online Ad Spending Sinking!
• Obama and Pharma: A More Perfect Union
• Centocor: First Pharma Company to Profile Employees on a Blog
- PharmaBlogosphere^TM
• I'm All a Twitter Over Twitter! Viral Social Marketing at Its Best?
• Reporting Gifts to Physicians -- on this I Agree
• Make Way for the 150-Second Vytorin TV Ad
• Is the Pharma Industry in a Recession?
• Cymbalta-Spitzer Contextual Web Advertising
• Pets Welcome, Pharma Not at Oregon CME Event
• Dear AstraZeneca: Please Invite Me to a Screening of Artery Explorer, the Interactive Version
• Centocor: Let Thy Employees Speak!
• Pfizer Reneges on DTC Pledge: Afternoon Viagra Ads Appear on ESPN
• Zetia "49 Strategy" -- Wine and Dine 'em Danno!
• Do You Have the "Legs" to Engage in Social Media Marketing?
• Overcoming Pharma's Employee Blogging Fears
• Centocor Blog - No Frying Pan and No Fire!
• We're #11, Shooting for TOP TEN in the Healthcare100 Blog List!
• Tauzin's Ant-Competitive, Anti-Free Choice Comments
• CNTO411: Centocor's Groundbreaking Blog

Posted in February, 2008:

• February Issue of Pharma Marketing News Available
• Jarvik: A Modern DTC Tragedy
• SNL Knows How to Spoof DTC Ads!
• Pfizer Flips. Jarvik Flops!
• User Fees for DTC Ad Review All Over Again
• World Without Broadcast DTC Would be a Boon to eMarketing
• Pharma Marketing People in the News
• Pharma's New Marketing Partner: Medical Journals
• FTC, Generics, and the War in Iraq
• Helping Pharma eMarketing "Grow Up"
• Pharma R&D Succumbs to the Dark Side
• Pens Put Brands in Docs' Brains and Profit in Pharma's Pockets
• Depression comes from two sources: Real Life and Vytorin
• The Professor's Straw Man Free Lunch for Physicians Argument
• Are Marketers Artists or Mathematicians?
• Social Media to Congress: "Piss Off!"
• Jarvik Can't Prescribe and Can't Row a Boat, But Can He Sell?
• Making Fun of Pharma Marketing is Easy
• What's Your Social Media Readiness Score?

Posted in January, 2008:

• Montel Says Goodbye to TV! May Leave PhRMA's PPA Program Also
• Caucuses, Coffee Shop Focus Groups, and Cholesterol
• Crestor Print Ad Touts Plaque Buildup Advantage
• Women Need More Love, Less Drugs
• Jarvik Falters in His Own Defense
• Vytorin and Zetia Are Dead in the Water
• New Vytorin TV Ads Are in the Works - IMHO
• Sleep Aid Drug Print Ad Triptych
• Different Views of Pharma and its Critics
• Consumer Reports Rip Rozerem Ad -- A New One!
• The Statin Lottery: Number Needed to Treat Statistic
• Duluth Bans Tchotchkes -- That's Snot Funny!
• FDA Won't be Previewing TV DTC Ads!
• My Cardiologist is on Vacation - "I'm as mad as hell..."
• Look Out for Sexier Cialis Ads -- Maybe Including Beaver!
• Should I Stop Taking Zetia?
• Did Pfizer Run a Chantix "Bookend" Ad During 60 Minutes?
• FDA DTC Payola Out, You Pay In!
• Rozerem Deep Sea Diver Debuts in New Yorker Cartoon Contest
• Jarvik -- Lipitor spokesperson -- "outed" as an unlicensed physician!
• Promotion vs. R&Deja vu all over again!

Posted in December, 2007:

• Giuliani's OxyContin (and PhRMA) Money
• Who Reads Pharma Marketing Blog?
• Is It Time to End Industry Sponsored CME?
• Mistletoe Viagra Dispenser: #1 Office Party Favor!
• Mevacor - STRIKE THREE! Yer Outta Here!
• Lunesta's Ad Spending Spree and Other DTC Oddities
• Lilly, Sweden, Bribes and Conspiracy Theories
• APA Report Rips Pharma a New One!
• DTC Critters to Strike - Cite New Media Residuals as Issue
• PGAD. EGAD! Another Syndrome/Disorder, Whatever!
• Can Big Pharma Avoid the Looming Patent Meltdown?
• Montel Williams Seeks Interns for 2008 - I Kid You Not!
• PhRMA Intern v. Montel: HS Intern is Saved, But...
• Montel Williams: Zero Tolerance for a Pharma Celebrity Spokesperson Gone Bad

Posted in November, 2007:

• Counter Detailing -- Pissing into the Wind or Profitable Endeavor?
• True Confessions Redux: Another MD Shill for Pharma Outed
• Dr. Carlat's True Confession: 199,999 More to Go
• Vytorin Study Stallin' - Notes from the Field Hands
• Dr. Buse Under GSK's Thumb! How Pharma Uses CME Funding as a Weapon.
• Merck to Vioxx Plaintiffs: Settle or Else!
• Is Money Being Wasted on Syndrome's Treatment?
• Amitiza DTC Ads Won't Win Any Awards, But...
• RLS Simulator: Weird Wired Science
• The "One-Click Rule": Rant or No Rant?
• AdAge is Wrong! Drug Ads, Not Bad News, Cause Frayed Attention Disorder (FAD)
• RLS Foundation (aka GSK?) Calls for Boycott of Consumer Reports Over Ad Spoof
• Accomplishing Adherence: Highlights from a Conference
• AbelsonTaylor's "Your Bowel Movements Miss You" Campaign Pitch for Amitiza
• The Natrecor Waterboard Tortured Tchotchke
• Lily-White Lilly. Homophobic and Sexist Too?
• What the US FDA Could Learn from China's FDA
• Lilly's Connelly: The Diversity Issue
• Andy Grove Calls for Pharma "Wild Ducks." Quack! Quack!
• Top Hat And Alli Tales
• Online CME Growth is Bad News for Pharma Marketers
• MM&M Award Winners Announced at Gala NY Event!
• AbelsonTaylor and I are off to the 2007 MM&M Awards Gala Event!

Posted in October, 2007:

• Another Award for Rozerem! This one...not so good.
• Awards. What Are They Good For?
• J&J Blog, Shire PR: The Whole Story and Nothing But the Whole Story!
• Rozerem Expedites Experts' Dreams: Honoraria!
• Awards: POE vs. MM&M. I Pick Winners!
• Pharma Grapples with Barriers to Adopting Web 2.0
• Pfizer the Headless Chicken!
• Sermo CEO Talks About Pfizer Collaboration
• Exubera: A Titanic Failure! What the survivors are saying.
• Exubera Bong Bombs!
• Pfizer has a Gold Mine in Sermo!
• Pfizer Facebook a la Sermo?
• Chantix Californication Dreamin': Viagra II
• Statins and Heart Disease: Look Behind the Curtain
• Medical Transcript Advertising: A Unique Form of "Non-Personal" Marketing
• Gardasil: Is the Risk of Being "One Less" Worth It?
• Gardasil: I Could Become One Less!
• Microsoft's HealthVault Fault
• Regulating DTC for BTC
• Lilly Cymbalta Marketers are NOT Practicing What Lilly Executives Preach!

Posted in September, 2007:

• A Pill, a Plan, a Profit? -- Chantix!
• POE: DTC Forevermore
• DTC Here to Stay; Pet Turtles Too!
• Web 2.0 Pharma Marketing Tricks for Dummies
• Risk-First DTC: A Tactic to Overcome Resistance
• An Innovative System for Communicating Drug Risks to Patients
• FDA Considers Color Code for Food Labels, But Not for Drug Labels
• My Prediction Vindicated: FluFlix Contest Entrants Will Sign Over Video Rights
• A Better Viva Viagra Ad
• Do Pharma Marketers Need a Thick Skin or Will a Thick Skull Suffice?
• Meet Dr. Andree Bates, Marketing ROI Expert
• What's Up with the Veramyst "Brief Summary" Print Ad?
• Novartis Attempts Perfect Execution of Web 2.0 Trick!
• Viva Lovey-Dovey Viagra!

Posted in August, 2007:

• Web 2.0: The New WILD, WILD WEST of the Internet!
• Cramer-Krasselt Sucks
• My Upcoming Speaking Gigs
• Wikis and Social Networks for Marketing & Sales Collaboration: Will It Work?
• FDA at a Mall Near You: The Manchurian Connection
• DTC Tsunami: Duh!
• Rozerem's Cheapskate Sweepstakes Violates Children's Online Privacy Protection Act
• State Sponsored Pharma Ads: It Could Happen!
• J&J Lawyers Go Wild; PR on Vacation!
• Takeda Plots New Rozerem Campaign?
• Brandweek Hires Peter Rost, Moves to the Dark Side!
• The Drug Advertising Blame Game

Posted in July, 2007:

• FDA's Chang and Eng: Benefit vs. Risk
• GSK's Race-based Herpes Awareness Campaign
• Social Network Analysis Good for Obesity Drug Marketing and Beyond!
• Why Do DTC Ads - "Viva Viagra" included - Stink?
• Viva Viagra Ad is No Cure for Morte Sales
• Mandatory Vaccination Controversy Did Not Hurt Gardasil Sales!
• Proximity Marketing: From Urinals to Doctors' Offices, Track Your "Target"
• Exubera TV Ad Lacks Bong, er, I mean Bang!
• What do Abe Lincoln, a beaver, and a bong have in common?
• The "RLS Gene" Story: Requip Ad Disguised as News on ABC
• DTC Industry Check-Up or Cherry-Pick?
• alli Marketer Explains "Treatment Effects"
• I'm Non-Objective and Proud of It!
• Why Grow Your Own Drugs When You Can Buy Them Off the Street?
• Advice to All Pharma PR Bloggers Out There
• CME: Continuing Marketing thru Education
• Moore's Blitzer Krieg
• Marketing's New Maxim: At Least Do No Harm!
• Is Advertising Democratic? Girl from Google Thinks So!
• Rejiggering the Marketing Mix a la Merck
• Google Not Gaga Over SiCKO. Has Remedy for Pharma
• Trade Publications Must Be More than Drug Industry Cheerleaders!

Posted in June, 2007:

• Google's "Old School" Health Advisory Council
• Pimp My Doc!
• PhRMA Intern Proves "No Strings Attached" to Pharma-Sponsored CME!
• Can an In-home Electronic Pillbox Solve Our Medication Error Problem?
• The Drug Industry Needs Constructive Criticism, Not Pugilistic Put Downs
• Rozerem DTC Ads: New Paradigm or Paradox?
• It Was Politics That Killed Avandia, Says Glaxo
• Rozerem Ad Spending Exceeds Sales!
• Pharma Marketing Blog is #11 in List of TOP 100 Healthcare Blogs!
• Free CME Without Direct Pharma Support: Is It Possible?
• Welcome to the CME Laundromat!
• FDA: Zimulti Non-Acomplia!
• Pharma Online Marketing: Got Game?
• Alli Newspeak: Oily Spotting is "Treatment Effect"
• PhRMA Intern Makes Movie Mogul an Offer He Can't Refuse!
• Cause Marketing via YouTube: What Pharma Can Learn from Michael Moore
• PhRMA Sent SiCKO Spy to Cannes
• SiCKO is Boffo but Not Anti-Pharmaco, per se
• Villanova Scientists Prove that DTC Spending Does Not Impact Rx Prices
• Avandia Hearing Soap Opera: Ethics, Demagogy, Sensationalism, and Threats by GSK
• Avandia Hearing Begins with Slurs Against NEJM and Majority Members
• Moore, Oprah, SiCKO: The Video
• Pharma's Worst Fear Realized: After Seeing SiCKO Oprah Calls for Town Hall Meeting
• PhRMA Report on DTC: Everything's Coming Up Roses!
• GSK's YouTube Disease Awareness Sponsorship
• Pharma Hires Charlatans for Research & Marketing!
• What is a Marketer's Goal: Legacy or Sales Today!?

Posted in May, 2007:

• AZ: No Cupcakes for You!
• On Cupcakes and HIPAA
• May Issue of Pharma Marketing News -- FREE! (Limited Time Offer)
• Is Big Pharma Shifty?
• Avandia: Enough Blame to Go Around
• GSK May "Step Into the [DTC] Void" to Defend Avandia
• Dumb Blonde Reps vs. Slovenly Genius Reps
• Temple vs. Nissen: Blood Rematch
• Alli Ad Campaign Promises Honesty, But Does It Deliver?
• Advice to GSK on Handling the Avandia Avalanche: Don't Do What Merck Did
• Innerstate: A Correction and Further Criticisms
• The Innerstate DVD. Is TV Next?
• Myth #1: High U.S. Drug Prices Guarantee Us First Shot at New Drugs
• Mr. Moore Don't Ignore: Please Invite Me to a Screening of Your Movie
• When is a Free Lunch More Than Just Lunch?
• No Goopy ED Gel in GSK's Futura
• Blog Readers' Opinions on Physician Marketing & Education Practices
• Blogs vs. DTC: What's Best for Consumers?
• Are Critical Bloggers "Enemies" of Pharma?
• Giuliani, OxyContin, Big Pharma, and Terrorism
• Pharma Marketing Blog Gets Another Top 5 "Must Read" Rating!
• Gardasil: Less Hype May Help
• Dollars for Docs: More Scrutiny Needed
• Imagine There's No DTC. I Wonder If You Can.
• Guidelines for Gifts to Patients
• BiDil Sales Disappoint: Blame Genes or Marketing?
• Yummi! It's Zimulti!
• Physician Empathy vs. Pre-Launch Marketing
• AZ's Missy Moran's MUMS Miasma
• Pfizer's Exubera Strategy Needs a Bong Blog!

Posted in April, 2007:

• Blogs Critical of Drug Industry Are Most Credible, Says Survey
• DUI: Dispensing Under the Influence
• Pfizer's Erection Hardness Meter
• J&J to Give 120,000 Employees Their Own Blogs?
• This is Your Inner Ear on Drugs!
• Americans Skeptical Of Pharma Cause Marketing
• Lilly Cuts PAP and Runs from Patients in Need, Putting Profits First
• New Twist to Pharma Chatchke Marketing: the Scrubs Affair
• BS Pharma Publishing Metrics
• Device DTC Ad Spend Sinks: Trend or Anomaly?
• Botox BS Piled Higher and Deeper
• Is Pfizer Outsourcing Innovation?
• 'Round the Sphere: You're Fired!
• Group of 7 (code name "whiskey") Reports Unethical AZ Behavior to OIG
• Pharma Still Stinks, But Not as Much as Oil or Tobacco!
• GSK Pulls Imus Ads...BUT, Only Until "Media Standards" Are Met
• Glaxo, Pull Your Imus Ads!
• A Few Rules for Pharma Employee Blogging
• The Zubillaga Affair: Effect on the Prospects for Pharma Blogging
• Botox Banality Not a Boon for TV Sitcoms
• Web 2.0 Hates Sally
• Celebrex Ad: Let's Dive Deeper
• The New Celebrex TV Ad: What Did You Learn?
• Device DTC: Imagine How Far It Will Go!
• Kindler's Refreshing View of Pharma's Problems and His Job

Posted in March, 2007:

• Basics of Sales Rep Watching
• Acomplia Not for the Gun Totting Bikini Crowd
• Dong-A PharmTech: New Erectile Dysfunction Drug
• Spend, Spend, Spend Before the End, End, End
• Dead DTC Golden Goose and Other Pharma Fears
• Dining at Pharma's Table
• von Eschenbach & Gonzales: Two Birds in the Same Bush
• FDA Advisor Rule Loophole?
• Rozerem Over There? Sic 'em Beav!
• J&J, You're No Elvis Presley!
• Nominate Me to the 100 List of Most Inspiring People!
• Takeda - Fire These Guys!
• Call for a Rozerem Prescription Boycott!
• Back to School for Takeda, Rozerem, and Abe Lincoln!
• Innerstate Private Screening: Philadelphia Style
• Are All Pharma Bloggers Biased Against the Industry?
• Drug Safety - A Mere Asterisk to the FDA
• Pharma Marketing Sitcoms as Brand Extensions
• Are you happy to see me, or is that just your Exubera Bong?
• Does Merck Need a Vaccine for Bad PR?

Posted in February, 2007:

• eGAD! How I Learned to Stop Worrying and Love Cymbalta!
• Merck's Refreshing Director of Global eMarketing
• No Oscar for Centocor PR Effort
• Vytorin Ads Are Getting Old -- and Disturbing!
• Who's Easier to Buy? A Physician or a Politician?
• Merck Quits Lobbying for Mandatory Gardasil Vaccination
• Marketing Drugs to Teens Online - So Wrong!
• PhRMA Responds to My Rozerem Ad "Concern"
• God Bless R&D, but Marketers May Go to Hell!
• Alli Oops! I Just Pooped Myself!
• Customer Manages Relationship: A New Marketing Strategy
• Pharma Super Bowl Ads Score Poorly
• Pharma Should Go Bollywood, Not Hollywood
• Prozac for Over Anxious Doggie Syndrome
• Rozerem DTC Emperor (Still) Has No Clothes
• GSK: Don't Go Cold Turkey!
• Gardasil: To Be Mandatory or Not To Be Mandatory -- That is the Question
• First Ever Pharma Blogosphere Survey!
• Debut of The Pharma Blogosphere: It's Raining Men!

Posted in January, 2007:

• Tilting Again at the PhRMA Windmill
• Pfizer PhD Phobia
• Barbie Drug Reps I'd Like to See
• Takeda: It Isn't a Reminder Ad --- Wha!!!
• Prilosec OTC Bunco Artists
• Rozerem Reverts to Reminder TV Ads
• Pharma Marketing Network Forum Update
• If Bill Gates Ran Pharma
• Disease Mongering and Pharma Credibility
• Revolution Health and the Wisdom of Crowds
• Nice Try, Daiichi!
• Banned from CafePharma!
• PDUFA Payola!
• Introducing...the All-Pharma Lobbying Lineup!
• A New Forum for Marketers!
• Viagra Spray Not Far Away?
• Web 2.0 for Pharma Marketing Podcast
• Lincoln Shot Dead! Beaver Sought for Questioning
• Brave New Pharma?
• If FDA were as Powerful as FTC
• Are Sales Reps Necessary?
• YouPharma(tm): A Brave New World of Marketing?
• DTC in the New Era

Posted in December, 2006:

• What Was Blogworthy in 2006? A Review
• Revamping the Lunesta Ad Campaign
• The Next Blockbuster - You Decide!
• Disease Mongering Podcast
• DTC Set to Surpass DTPhysician
• Where's DDMAC's Head At?
• Merck on a Roll
• Celebrex Joins the bAdWord Bandwagon!
• Physician Blogging - Survey Results
• Tufts Hangs Tough on Opportunity Cost Analysis
• Is Pfizer Arrogant and Superior?
• Betting the Pharm
• torcetrapib: "$800 Million" Failure but Kindler Safe
• Pfizer's torcetrapib: Who Knew What, When?
• Compliance, Math, and Marketers

Posted in November, 2006:

• Out with the Bad, In with the Good
• Off-Label Confusion
• Am I Dreaming, or Is This a Rozerem Ad?
• Levitra Levity
• Chantix: Opportunity for Social Marketing Lost?
• Lame-Duck Senate Roasts Eschenbach Turkey!
• Pay Per DTC Ad View Update
• Wooing Dems: Thank You Mr. Kindler!
• What's In Store from Congress?
• Not Your Father's eDetail
• The "Girl from Google"
• Influencing the Dialogue: Marketers Suck at It!
• Upcoming "Pharma Marketing Talk" Podcast
• The Long Road to DTC Excellence
• Do New Drugs Prolong Lives?
• What a Difference a Day Makes!
• CommonHealth's Selective Release of DTC Study Data
• Clear Words, Obscure Benefits
• Lunesta, Google, and "bAdWords"
• Marketer vs. Marketeer: Synonymous?
• Rozerem Sleeper Cell at Pri-Med Conference

Posted in October, 2006:

• AmbienCR and Lunesta Duke It Out on Web
• Awards: The Good, The Bad, The Ugly
• Rozerem Ads Innovatively Ineffectual
• Allergan Ignores Guidelines, Wins Award Anyway
• Interpretation of Ads: Hokey vs. Horny
• CGC: Old Wine in New Bottles
• Lipitor's Jarvik: Fop or Flop?
• Marketing 101: Newer is Better
• Product Web Sites Not Up to Par
• Print DTC, PhRMA Guidelines, and Balance
• Free Lunch Redux
• Snark Meter
• Pharma Support for CME Slows
• Free Lunch for Physicians: Newsweek Misleads
• Imprecise DTC Benefit Messages

Posted in September, 2006:

• Odds & Ends & Interpretations
• Apres IOM, le Deluge!
• IOM Report Calls for DTC Moratorium
• PhRMA's OOA Issues First Report
• Marketing Executive Salaries
• Pharma eMarketing in a Slump
• Advertisers Don't Know How DTC Works. Say wha?
• Rozerem Beaver Buzz
• The Call Center from Hell
• Another Pharma CEO Bites the Dust!
• Pharma's Black Knight Parties On!
• Health Literacy - Words Fail to Tell the Story
• Merck Management Is "Exonerated"
• Polypill: Predicted Here First!
• Web DTC Video: Boon or Bane?
• Pay-(FDA)-Per-(Pre)View of DTC

Posted in August, 2006:

• Kindler, Cheney: Kindred Spirits?
• Caduet, Smaduet! Add some wood to the fire!
• Marketing plan A for Plan B
• Market Research: Privacy Matters
• Levitra Market Research: The Interview
• My Sojourn as Market Research Subject for Levitra
• Precision Buzz Marketing
• WLF: A No-Risk Ad is a Good Ad
• Confusing Creativity with Mission
• Brand Extinction Looms
• McKinnell's New Gig: Male Model
• Sicko si, Pharmaco no!?
• Patient Advocacy Marketing: US vs Them
• Vioxx Scorecard: 5-3-14192
• Kindler Fox in Pfizer Henhouse (aka Bunker)
• Anonymous Online Marketing
• Accountability: Imported vs. Domestic
• Free lunch for patients! Why not?

Posted in July, 2006:

• PhRMA Intern Tackles Terrorists!
• Generics: Physicians Less Informed than Consumers!
• Rules of Engagement
• Lunesta, a Sleeping Dog
• PhRMA Intern vs. the Pharma PR Agency!
• Fear & Loathing in Bethesda
• A Milestone Is Reached!
• DTC Menagerie & Bad Buzz
• Rozerem Ads Dis Lincoln, Show Beaver
• PhRMA Intern vs. BOTOX!
• Question Everything
• The Adventures of PhRMA Intern!
• The Marketing Mix Maze
• DTC, Elections, and PhRMA
• PhRMA's Response - PRwise, it Stinks!
• Chantix: PR First, Launch & Ads to Follow

Posted in June, 2006:

• PR Marketing: Mystery Wrapped in a Riddle
• Marketing Disguised as PR
• AMA vs DTC: Spinmeisters at Work
• CME: Promotion vs Education
• Fat Acomplia?
• Two Sources of Zocor
• Behavioral Targeting: RJ vs JP
• Blockbuster or Ballbuster?
• Sales Force Effectiveness
• Medical Device DTC: What's Up With That?
• FDA Paralyzed: Who Will Protect Us?
• Welcome Back Vioxx, Welcome Back
• Licensing Sales Reps: Is It a Bad Idea?
• Industry PR & Rep Morale
• Restless Brush Syndrome: Lessons for Requip Marketers
• Drug Risks: Consumers Less Concerned than Docs
• Pharma Use of Rx Data Survey
• Pharma Tail Wags Patient Dogs

Posted in May, 2006:

• How to Piss Off KOLs
• FDA Gets a "C" from the Public
• Doing a Good Job but Still No Respect!
• More Reminder Ad Sightings
• Specious Arguments in Favor of Rx Data Use
• Why Drug Companies Promote Off-Label
• We Were Hoodwinked!
• DTC Placebo Effect
• Pharma and Republicans Part Ways
• Pharma Industry "Less Unpopular"
• Pfizer Imitating Art or Vice Versa?
• Whose Data Is It Anyway?
• Wake Up PhRMA! or Tilting at Windmills
• Pre-emptive Drug Marketing?
• Celsius 3014: Ketek, Drug Safety, & Bioterrorism

Posted in April, 2006:

• Lunesta: Golden or Bitter Pill?
• How Not to Influence Physician Bloggers
• Spinning Bad News about FDA & Drug Safety
• FDA Coming to a Mall Near You?
• Sepracor Sneaks In Lunesta Reminder Ad
• Restless Pharma Marketing
• Disease Awareness or "Disease Mongering?"
• DTC without Risk Revisited
• Merck Misled FDA According to NJ Jury
• Rost to Roost in Blogosphere
• Clash!

Posted in March, 2006:

• DTC without the Risk
• Drug Development: Science vs. Marketing
• Buzz 'n Blogs -- Stealth Marketing
• Immutable Laws of DTC Domain Naming
• Paid Inclusion: Too Hot for Pharma Marketing?

Posted in February, 2006:

• Off-label Marketing: Next State Issue
• GSK's "Plain Talk" Flawed
• Pharma PR: It's All About Defending Drug Prices
• Sales Reps Make Poor Spokespeople
• Avastin - Supersize Profiteering!
• FDA Backs Down on Coupon Study
• Gen X Reps Revisited
• Generation X Pharma Reps
• FDA, Coupons, and Sleep Aid DTC Ads
• Cialis Blog Shut Down
• Michael Moore Seeks "Sickos"
• Cialis Blog -- Shame on Lilly ICOS

Posted in January, 2006:

• Gifts That Keep on Giving
• Challenges Ahead for Pharma
• The End of DTC as We Have Known It
• Finally, Marketing Aligns with PR - Maybe
• 2006 Pharma Trend Survey
• Pharma's Jekyll & Hyde
• This Blogger's Mission Statement
• Pfizer - the Rodney Dangerfield of the Drug Industry
• New Year's Resolutions for Pharma

Posted in December, 2005:

• The BEST of Pharma Marketing Blog in 2005
• Lilly's Off-Label Promo Shenanigans
• Pharmaceutical "Tribal Marketing"
• Marketing "Acceptable Risk"
• Merck's Hand in the Cookie Jar
• Less DTC, Better Public Image?
• J&J Scores High in Reputation Quotient Study
• Why are ED drug sales falling?
• Coming Soon: Sexy eDetailing

Posted in November, 2005:

• Jerry Hall, Women and Pharma Marketing
• Merck to Shed Fat, But Not in Sales & Marketing
• Sexy Reps Sell Rx
• Pfizer Tries Unbranded ED DTC Ads
• AstraZeneca's Risky Proposition
• WSJ Cites PM Blog as "Must Read"
• Plan B FDAgate
• Preview of Upcoming Articles
• Why unbranded ads don't work
• FDA DTC Hearings Day 2
• FDA DTC Hearings: Snippets from Day 1

Posted in October, 2005:

• DTC Regulation: Trick or Treat?
• Tobacco & Drugs: Strange Bedfellows
• DTC and Older Americans
• The Empire Strikes Back
• PhRMA's Terrorist Plot
• Cut Marketing, Raise Sales!
• New Assault on Pharma Marketing?
• Celebrities & Buzz Revisited
• Fake Pharma Advertising
• eDetailing: Surveys Say...
• DTC & Prescribing: Conventional Wisdom Challenged

Posted in September, 2005:

• Insomnia - the Next DTC Frontier
• FDA May Follow PhRMA's Lead on DTC
• Vioxx Hex or Hoax?
• Vagelos Speaks. Will Pharma Listen?
• Pfizer No Longer Top 10 Advertiser
• After School Cialis Ads
• Pharma Industry's Relief Effort
• Online Marketing Ethics, Part 1

Posted in August, 2005:

• Saving Public Merck
• Ethical Pharma Marketing: Oxymoronic?
• Pharma Image Makeover Tactics Unconvincing
• Merck Changes Tactics, Lawyers Too
• Are Pharma Ad $ Moving Online?
• Merck science "like wah, wah, wah"
• Jury as Focus Group
• Merck Found Negligent!
• Pharma Marketing Newspeak
• Alternative to DTC: cDetailing
• Movies and Drugs: Same Blockbuster Mentality
• Pfizer DTC Pledge: ED is Litmus Test
• Internet Marketing: Risks Ahead
• Bloggers Worry Pharma More Than FDA
• Alternatives to DTC, Part 1
• Reminder Ads - Pharma's Dodo?
• PhRMA Finalizes DTC Principles
• Healthy Pharma 2010

Posted in July, 2005:

• McKinnell's Mea Non Culpa
• Restrict DTC, but Extend the Patent for New Drugs
• Physician Education vs. Promotion
• Transparency: A New Voice for Pharma
• Labeling / TV DTC Revisited
• Indication Bloat - The Next DTC Issue
• Deconstructing Frist on DTC
• To Ban or Not to Ban DTC, That is the Question
• DTC - Best of Times, Worst of Times

Posted in June, 2005:

• Pharma eMarketing at Tipping Point?
• HELP WANTED: Director of Drug Safety
• WLF Watches FDA Watching Drug Ads
• Future of Drug Print Ads
• New DTC Principles Emerging
• Ethnic Drugs - Good Science or Good Marketing?
• Say it isn't so, J&J!
• Can't Get Any Respect!
• Peter Rost: Pharma's Black Knight
• eDetailing ROI Better Than DTC?
• Patients Come First?

Posted in May, 2005:

• You'll Go Blind!
• PEED: A New Viagra Franchise?
• Is Pharmaceutical Marketing BS?
• Pull Back from DTC on TV?
• Terror Politics vs Drug Importation
• Proposal for a Drug Risk Advisory System
• FDA Drug Watch Site Guidelines
• Get a Load of Those Gams!
• The Two Bobs: Enzyte vs. Viagra
• Innovative Drugs Deserve Innovative Marketing

Posted in April, 2005:

• Evidence-based Marketing
• Blame the Doc, Not DTC!
• The Drug Sampling Problem
• Separation of Church and State
• Cox-2's (and Pfizer?) on Slippery Slope
• "Bioshield" Boondoggle

Posted in March, 2005:

• John Mack Rebuffs MerckÂ’s CEO Offer
• DTC Straight Talk
• Give Docs What They Want
• "Ethnic Drugs" and "Genetic Marketing"
• Pharma Marketing Mensa Invitational
• DTC Laissez-faire: A Bankrupt Policy

Posted in February, 2005:

• It's the land of success!
• Pfizer to Slash 30% of its Sales & Marketing Staff
• Pharma Sales Force Bloat and the Mythical Man-Month
• Time for Pharma to Revamp Its Physician Marketing Strategy
• Drug Safety: A Matter of Trust!
• Vioxx Redux
• FDA Advisory Panels: Elephants in the Room

Posted in January, 2005:

• Drug Companies Give Aid to Tsunami Victims
• Cox-2's Die Hard: With a Vengeance
• Who Should Pay for Merck's Obstructionism?
• The Pharma Industry Has Issues in 2005
• Canada: Mad Cows Yes, Drugs No!
• The End of DTC as We Know It
• ED Drug Sales Limp
• Drug Prices, Declining Profits Top Pharma Concern
• Does the FDA Need to be Overhauled?
• How the FDA Can Fix DTC
• Drug Prices/Declining Profits Top Issues for 2005
• Pharma Profits on Slippery Slope?
• Marketing Drugs Like Packaged Goods at the Super Bowl
• Pharmaceutical PR: Fool Me Once, Fool Me Twice
• DTC in 2005: Old Dogs, New Tricks?
• Can Drug Ads Communicate Risk?
• Buzz is NOT regulated by FDA